{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T16:16:26Z","timestamp":1791044186102,"version":"4.1.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2009,7,21]],"date-time":"2009-07-21T00:00:00Z","timestamp":1248134400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurotox Res"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1007\/s12640-009-9087-0","type":"journal-article","created":{"date-parts":[[2009,7,20]],"date-time":"2009-07-20T11:58:28Z","timestamp":1248091108000},"page":"114-129","source":"Crossref","is-referenced-by-count":118,"title":["Single Intranasal Administration of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine in C57BL\/6 Mice Models Early Preclinical Phase of Parkinson\u2019s Disease"],"prefix":"10.1007","volume":"17","author":[{"given":"Rui D. S.","family":"Prediger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Aderbal S.","family":"Aguiar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Argelia Esperanza","family":"Rojas-Mayorquin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia P.","family":"Figueiredo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filipe C.","family":"Matheus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure","family":"Ginestet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Chevarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine Del","family":"Bel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Mongeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Hamon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Lanfumey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Raisman-Vozari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,7,21]]},"reference":[{"key":"9087_CR1","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/0006-8993(82)90117-2","volume":"238","author":"A Albanese","year":"1982","unstructured":"Albanese A, Bentivoglio M (1982) The organization of dopaminergic and nondopaminergic mesencephalocortical neurons in the rat. Brain Res 238:421\u2013425","journal-title":"Brain Res"},{"key":"9087_CR2","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1146\/annurev.ne.09.030186.002041","volume":"9","author":"GE Alexander","year":"1986","unstructured":"Alexander GE, DeLong MR, Strick PL (1986) Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 9:357\u2013381","journal-title":"Annu Rev Neurosci"},{"key":"9087_CR3","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1006\/exnr.1998.6995","volume":"155","author":"E Bezard","year":"1999","unstructured":"Bezard E, Gross CE, Fournier MC, Dovero S, Bloch B, Jaber M (1999) Absence of MPTP-induced neuronal death in mice lacking the dopamine transporter. Exp Neurol 155:268\u2013273","journal-title":"Exp Neurol"},{"key":"9087_CR4","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1080\/01688639108401048","volume":"13","author":"MW Bondi","year":"1991","unstructured":"Bondi MW, Kaszniak AW (1991) Implicit and explicit memory in Alzheimer\u2019s disease and Parkinson\u2019s disease. J Clin Exp Neuropsychol 13:339\u2013358","journal-title":"J Clin Exp Neuropsychol"},{"key":"9087_CR5","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1007\/s00702-004-0168-1","volume":"111","author":"JL Bosboom","year":"2004","unstructured":"Bosboom JL, Stoffers D, Wolters ECh (2004) Cognitive dysfunction and dementia in Parkinson\u2019s disease. J Neural Transm 111:1303\u20131315","journal-title":"J Neural Transm"},{"key":"9087_CR6","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","volume":"318","author":"H Braak","year":"2004","unstructured":"Braak H, Ghebremedhin E, Rub U, Bratzke H, Del Tredici K (2004) Stages in the development of Parkinson\u2019s disease-related pathology. Cell Tissue Res 318:121\u2013134","journal-title":"Cell Tissue Res"},{"key":"9087_CR7","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.neurobiolaging.2004.07.014","volume":"26","author":"A Bruck","year":"2005","unstructured":"Bruck A, Aalto S, Nurmi E, Bergman J, Rinne JO (2005) Cortical 6-[18F]fluoro-l-dopa uptake and frontal cognitive functions in early Parkinson\u2019s disease. Neurobiol Aging 26:891\u2013898","journal-title":"Neurobiol Aging"},{"key":"9087_CR8","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0014-2999(84)90221-8","volume":"100","author":"C Chiueh","year":"1984","unstructured":"Chiueh C, Markey SP, Burns RS, Johannessen JN, Pert A, Kopin IJ (1984) Neurochemical and behavioral effects of systemic and intranigral administration of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the rat. Eur J Pharmacol 100:189\u2013194","journal-title":"Eur J Pharmacol"},{"key":"9087_CR9","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1093\/brain\/115.6.1701","volume":"115","author":"JA Cooper","year":"1992","unstructured":"Cooper JA, Sagar HJ, Doherty SM, Jordan N, Tidswell P, Sullivan EV (1992) Different effects of dopaminergic and anticholinergic therapies on cognitive and motor function in Parkinson\u2019s disease. A follow-up study of untreated patients. Brain 115:1701\u20131725","journal-title":"Brain"},{"key":"9087_CR10","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/0006-8993(91)91365-8","volume":"564","author":"R Coopersmith","year":"1991","unstructured":"Coopersmith R, Weihmuller FB, Kirstein CL, Marshall JF, Leon M (1991) Extracellular dopamine increase in neonatal olfactory bulb during odor preference training. Brain Res 564:149\u2013153","journal-title":"Brain Res"},{"key":"9087_CR11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0166-4328(01)00211-X","volume":"124","author":"C Da Cunha","year":"2001","unstructured":"Da Cunha C, Gevaerd MS, Vital MA, Miyoshi E, Andreatini R, Silveira R, Takahashi RN, Canteras NS (2001) Memory disruption in rats with nigral lesions induced by MPTP: a model for early Parkinson\u2019s disease amnesia. Behav Brain Res 124:9\u201318","journal-title":"Behav Brain Res"},{"key":"9087_CR12","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/BF00518192","volume":"91","author":"R Dantzer","year":"1987","unstructured":"Dantzer R, Bluthe RM, Koob GF, Le Moal M (1987) Modulation of social memory in male rats by neurohypophyseal peptides. Psychopharmacology 91:363\u2013368","journal-title":"Psychopharmacology"},{"key":"9087_CR13","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/0006-8993(92)91385-R","volume":"586","author":"DE Dluzen","year":"1992","unstructured":"Dluzen DE (1992) 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) reduces norepinephrine concentrations in the olfactory bulbs of male mice. Brain Res 586:144\u2013147","journal-title":"Brain Res"},{"key":"9087_CR14","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S0006-8993(96)00934-1","volume":"741","author":"DE Dluzen","year":"1996","unstructured":"Dluzen DE, Kefalas G (1996) The effects of intranasal infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) upon catecholamine concentrations within olfactory bulbs and corpus striatum of male mice. Brain Res 741:215\u2013219","journal-title":"Brain Res"},{"key":"9087_CR15","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/0006-8993(93)90860-P","volume":"609","author":"DE Dluzen","year":"1993","unstructured":"Dluzen DE, Kreutzberg JD (1993) 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) disrupts social memory\/recognition processes in the male mouse. Brain Res 609:98\u2013102","journal-title":"Brain Res"},{"key":"9087_CR16","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0304-3940(98)00691-0","volume":"254","author":"DE Dluzen","year":"1998","unstructured":"Dluzen DE, Muraoka S, Landgraf R (1998) Olfactory bulb norepinephrine depletion abolishes vasopressin and oxytocin preservation of social recognition responses in rats. Neurosci Lett 254:161\u2013164","journal-title":"Neurosci Lett"},{"key":"9087_CR17","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/ana.21327","volume":"63","author":"RL Doty","year":"2008","unstructured":"Doty RL (2008) The olfactory vector hypothesis of neurodegenerative disease: is it viable? Ann Neurol 63:7\u201315","journal-title":"Ann Neurol"},{"key":"9087_CR18","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1007\/BF00451680","volume":"98","author":"RL Doty","year":"1989","unstructured":"Doty RL, Risser JM (1989) Influence of the D2 dopamine receptor agonist quinpirole on the odor detection performance of rat before and after spiperone administration. Psychopharmacology 98:310\u2013315","journal-title":"Psychopharmacology"},{"key":"9087_CR19","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1212\/WNL.38.8.1237","volume":"38","author":"RL Doty","year":"1988","unstructured":"Doty RL, Deems D, Stellar S (1988a) Olfactory dysfunction in Parkinson\u2019s disease: a general deficit unrelated to neurologic signs, disease state, or disease duration. Neurology 38:1237\u20131244","journal-title":"Neurology"},{"key":"9087_CR20","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/0006-8993(88)90917-1","volume":"444","author":"RL Doty","year":"1988","unstructured":"Doty RL, Fergusson-Segall M, Lucki I, Kreider M (1988b) Effects of intrabulbar injections of 6-hydroxydopamine on ethyl acetate odor detection in castrate and non-castrate male rats. Brain Res 444:95\u2013103","journal-title":"Brain Res"},{"key":"9087_CR21","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1006\/neur.1995.0011","volume":"4","author":"RL Doty","year":"1995","unstructured":"Doty RL, Bromley SM, Stern MB (1995) Olfactory testing as an aid in the diagnosis of Parkinson\u2019s disease: development of optimal discrimination criteria. Neurodegeneration 4:93\u201397","journal-title":"Neurodegeneration"},{"key":"9087_CR22","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1006\/exnr.2002.7935","volume":"176","author":"A Douhou","year":"2002","unstructured":"Douhou A, Debeir T, Murer MG, Do L, Dufour N, Blanchard V, Moussaoui S, Bohme GA, Agid Y, Raisman-Vozari R (2002) Effect of chronic treatment with riluzole on the nigrostriatal dopaminergic system in weaver mutant mice. Exp Neurol 176:247\u2013253","journal-title":"Exp Neurol"},{"key":"9087_CR23","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/PL00007725","volume":"244","author":"B Dubois","year":"1997","unstructured":"Dubois B, Pillon B (1997) Cognitive deficits in Parkinson\u2019s disease. J Neurol 244:2\u20138","journal-title":"J Neurol"},{"key":"9087_CR24","volume-title":"Parkinson\u2019s disease","author":"RC Duvoisin","year":"1991","unstructured":"Duvoisin RC (1991) Parkinson\u2019s disease, 3rd edn. Raven Press, New York","edition":"3"},{"key":"9087_CR25","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0006-8993(97)00593-3","volume":"762","author":"EF Espejo","year":"1997","unstructured":"Espejo EF (1997) Selective dopamine depletion within the medial prefrontal cortex induces anxiogenic-like effects in rats placed on the elevated plus maze. Brain Res 762:281\u2013284","journal-title":"Brain Res"},{"key":"9087_CR26","doi-asserted-by":"publisher","first-page":"3413","DOI":"10.1073\/pnas.0409713102","volume":"102","author":"F Fornai","year":"2005","unstructured":"Fornai F, Schl\u00fcter OM, Lenzi P, Gesi M, Ruffoli R, Ferrucci M, Lazzeri G, Busceti CL, Pontarelli F, Battaglia G, Pellegrini A, Nicoletti F, Ruggieri S, Paparelli A, S\u00fcdhof TC (2005) Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin-proteasome system and alpha-synuclein. Proc Natl Acad Sci USA 102:3413\u20133418","journal-title":"Proc Natl Acad Sci USA"},{"key":"9087_CR27","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1016\/j.lfs.2007.02.021","volume":"80","author":"J Franco","year":"2007","unstructured":"Franco J, Prediger RD, Pandolfo P, Takahashi RN, Farina M, Dafre AL (2007) Antioxidant responses and lipid peroxidation following intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration in rats: increased susceptibility of olfactory bulb. Life Sci 80:1906\u20131914","journal-title":"Life Sci"},{"key":"9087_CR28","volume-title":"The mouse brain in stereotaxic coordinates","author":"KBJ Franklin","year":"1997","unstructured":"Franklin KBJ, Paxinos G (1997) The mouse brain in stereotaxic coordinates. Academic Press, San Diego"},{"key":"9087_CR29","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/cne.902660302","volume":"266","author":"CM Gall","year":"1987","unstructured":"Gall CM, Hendry SH, Seroogy KB, Jones EG, Haycock JW (1987) Evidence of coexistence of GABA and dopamine in neurons of the rat olfactory bulb. J Comp Neurol 266:307\u2013318","journal-title":"J Comp Neurol"},{"key":"9087_CR30","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1007\/BF01291788","volume":"103","author":"M Gerlach","year":"1996","unstructured":"Gerlach M, Riederer P (1996) Animal models of Parkinson\u2019s disease: an empirical comparison with the phenomenology of the disease in man. J Neural Transm 103:987\u20131041","journal-title":"J Neural Transm"},{"key":"9087_CR31","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1212\/WNL.50.5.1346","volume":"50","author":"JM Gorell","year":"1998","unstructured":"Gorell JM, Johnson CC, Rybicki BA, Peterson EL, Richardson RJ (1998) The risk of Parkinson\u2019s disease with exposure to pesticides, farming, well water, and rural living. Neurology 50:1346\u20131350","journal-title":"Neurology"},{"key":"9087_CR32","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1212\/WNL.50.5.1327","volume":"50","author":"JH Growdon","year":"1998","unstructured":"Growdon JH, Kieburtz K, McDermott MP, Panisset M, Friedman JH (1998) Levodopa improves motor function without impairing cognition in mild non-demented Parkinson\u2019s disease patients. Parkinson Study Group. Neurology 50:1327\u20131331","journal-title":"Neurology"},{"key":"9087_CR33","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/0306-4522(83)90206-3","volume":"10","author":"N Halasz","year":"1983","unstructured":"Halasz N, Shepherd GM (1983) Neurochemistry of the vertebrate olfactory bulb. Neuroscience 10:759","journal-title":"Neuroscience"},{"key":"9087_CR34","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0022-3565(25)22158-9","volume":"246","author":"M Hamon","year":"1988","unstructured":"Hamon M, Fattaccini CM, Adrien J, Gallissot MC, Martin P, Gozlan H (1988) Alterations of central serotonin and dopamine turnover in rats treated with ipsapirone and other 5-hydroxytryptmaine 1A agonists with potential anxiolytic properties. J Pharmacol Exp Ther 246:745\u2013752","journal-title":"J Pharmacol Exp Ther"},{"key":"9087_CR35","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/B978-0-12-185269-6.50010-2","volume":"10","author":"EC Hirsch","year":"1992","unstructured":"Hirsch EC, Lejeune O, Colliot G, Corkidi G, Tajani M (1992) Computer methods in nuclei cartography. Methods Neurosci 10:62\u201379","journal-title":"Methods Neurosci"},{"key":"9087_CR36","first-page":"S16","volume":"2","author":"P Jenner","year":"2008","unstructured":"Jenner P (2008) Functional models of Parkinson\u2019s disease: a valuable tool in the development of novel therapies. Ann Neurol Suppl 2:S16\u2013S29","journal-title":"Ann Neurol Suppl"},{"key":"9087_CR37","doi-asserted-by":"publisher","first-page":"3521","DOI":"10.1073\/pnas.84.10.3521","volume":"84","author":"RN Kalaria","year":"1987","unstructured":"Kalaria RN, Mitchell MJ, Harik SI (1987) Correlation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity with blood-brain barrier monoamine-oxidase activity. Proc Natl Acad Sci USA 84:3521\u20133525","journal-title":"Proc Natl Acad Sci USA"},{"key":"9087_CR38","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1046\/j.1460-9568.2003.02864.x","volume":"18","author":"S Kaul","year":"2003","unstructured":"Kaul S, Kanthasamy A, Kitazawa M, Anantharam V, Kanthasamy AG (2003) Caspase-3 dependent proteolyytic activation of protein kinase C delta mediates and regulates 1-methyl-4-phenylpyridinium (MPP+)-induced apoptotic cell death in dopaminergic cells: relevance to oxidative stress in dopaminergic degeneration. Eur J Neurosci 18:1387\u20131401","journal-title":"Eur J Neurosci"},{"key":"9087_CR39","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1111\/j.1471-4159.1982.tb03953.x","volume":"39","author":"T Kawano","year":"1982","unstructured":"Kawano T, Margolis FL (1982) Transsynaptic regulation of olfactory bulb catecholamines in mice and rats. J Neurochem 39:342\u2013348","journal-title":"J Neurochem"},{"key":"9087_CR40","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1126\/science.6823561","volume":"219","author":"JW Langston","year":"1983","unstructured":"Langston JW, Ballard P, Tetrud JW, Irwin I (1983) Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219:979\u2013980","journal-title":"Science"},{"key":"9087_CR41","doi-asserted-by":"crossref","first-page":"6351","DOI":"10.1523\/JNEUROSCI.23-15-06351.2003","volume":"23","author":"SJG Lewis","year":"2003","unstructured":"Lewis SJG, Dove A, Robbins TW, Barker RA, Owen AM (2003) Cognitive impairments in early Parkinson\u2019s disease are accompanied by reductions in activity in frontostriatal neural circuitry. J Neurosci 23:6351\u20136356","journal-title":"J Neurosci"},{"key":"9087_CR42","first-page":"180","volume":"92","author":"RG Lister","year":"1987","unstructured":"Lister RG (1987) The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology 92:180\u2013185","journal-title":"Psychopharmacology"},{"key":"9087_CR43","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/35040009","volume":"1","author":"MP Mattson","year":"2000","unstructured":"Mattson MP (2000) Apoptosis in neurodegenerative disorders. Nat Rev Mol Cell Biol 1:120\u2013129","journal-title":"Nat Rev Mol Cell Biol"},{"key":"9087_CR44","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1111\/j.1471-4159.1986.tb00722.x","volume":"47","author":"RA Mayer","year":"1986","unstructured":"Mayer RA, Kindt MV, Heikkila RE (1986) Prevention of the nigrostriatal toxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by inhibitors of 3,4-dihydroxyphenylethylamine transport. J Neurochem 47:1073\u20131079","journal-title":"J Neurochem"},{"key":"9087_CR45","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.neures.2004.09.012","volume":"51","author":"Y Mitsumoto","year":"2005","unstructured":"Mitsumoto Y, Mori A, Ohashi S, Nakai M, Moriizumi T (2005) Differential effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the olfactory bulb and the striatum in mice. Neurosci Res 51:111\u2013115","journal-title":"Neurosci Res"},{"key":"9087_CR46","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0361-9230(02)00754-2","volume":"58","author":"E Miyoshi","year":"2002","unstructured":"Miyoshi E, Wietzikoski S, Camplessei M, Silveira R, Takahashi RN, Da Cunha C (2002) Impaired learning in a spatial working memory version and in a cued version of the water maze in rats with MPTP-induced mesencephalic dopaminergic lesions. Brain Res Bull 58:41\u201347","journal-title":"Brain Res Bull"},{"key":"9087_CR47","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/s007020200013","volume":"109","author":"A Muller","year":"2002","unstructured":"Muller A, Reichmann H, Livermore A, Hummel T (2002) Olfactory function in idiopathic Parkinson\u2019s disease (IPD): results from cross-sectional studies in IPD patients and long-term follow-up of de-novo IPD patients. J Neural Transm 109:805\u2013811","journal-title":"J Neural Transm"},{"key":"9087_CR48","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.conb.2004.03.003","volume":"14","author":"D Passingham","year":"2004","unstructured":"Passingham D, Sakai K (2004) The prefrontal cortex and working memory: physiology and brain imaging. Curr Opin Neurobiol 14:163\u2013168","journal-title":"Curr Opin Neurobiol"},{"key":"9087_CR49","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/S0306-4522(01)00295-0","volume":"106","author":"E Petroske","year":"2001","unstructured":"Petroske E, Meredith GE, Callen S, Totterdell S, Lau YS (2001) Mouse model of Parkinsonism: a comparison between subacute MPTP and chronic MPTP\/probenecid treatment. Neuroscience 106:589\u2013601","journal-title":"Neuroscience"},{"key":"9087_CR50","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1212\/WNL.39.6.762","volume":"39","author":"B Pillon","year":"1989","unstructured":"Pillon B, Dubois B, Bonnet AM, Esteguy M, Guimaraes J, Vigouret JM, Lhermitte F, Agid Y (1989) Cognitive slowing in Parkinson\u2019s disease fails to respond to levodopa treatment: the 15-objects test. Neurology 39:762\u2013768","journal-title":"Neurology"},{"key":"9087_CR51","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1002\/ana.410290616","volume":"29","author":"W Poewe","year":"1991","unstructured":"Poewe W, Berger W, Benke T, Schelosky L (1991) High-speed memory scanning in Parkinson\u2019s disease: adverse effects of levodopa. Ann Neurol 29:670\u2013673","journal-title":"Ann Neurol"},{"key":"9087_CR52","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.bbr.2003.11.009","volume":"153","author":"RD Prediger","year":"2004","unstructured":"Prediger RD, Batista LC, Miyoshi E, Takahashi RN (2004) Facilitation of short-term social memory by ethanol in rats is mediated by dopaminergic receptors. Behav Brain Res 153:149\u2013157","journal-title":"Behav Brain Res"},{"key":"9087_CR53","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.neurobiolaging.2004.08.012","volume":"26","author":"RD Prediger","year":"2005","unstructured":"Prediger RD, Batista LC, Takahashi RN (2005a) Caffeine reverses age-related deficits in olfactory discrimination and social recognition memory in rats. Involvement of adenosine A1 and A2A receptors. Neurobiol Aging 26:957\u2013964","journal-title":"Neurobiol Aging"},{"key":"9087_CR54","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1097\/01.fbp.0000166825.62130.9a","volume":"16","author":"RD Prediger","year":"2005","unstructured":"Prediger RD, Da Cunha C, Takahashi RN (2005b) Antagonistic interaction between adenosine A2A and dopamine D2 receptors modulates the social recognition memory in reserpine-treated rats. Behav Pharmacol 16:209\u2013218","journal-title":"Behav Pharmacol"},{"key":"9087_CR55","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.expneurol.2006.07.001","volume":"202","author":"RD Prediger","year":"2006","unstructured":"Prediger RD, Batista LC, Medeiros R, Pandolfo P, Florio JC, Takahashi RN (2006) The risk is in the air: intranasal administration of MPTP to rats reproducing clinical features of Parkinson\u2019s disease. Exp Neurol 202:391\u2013403","journal-title":"Exp Neurol"},{"key":"9087_CR56","doi-asserted-by":"publisher","unstructured":"Prediger RD, Rial D, Medeiros R, Figueiredo CP, Doty RL, Takahashi RN (2009) Risk is in the air: an intranasal MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) rat model of Parkinson\u2019s disease. Ann N Y Acad Sci. doi: 10.1111\/j.1749-6632.2009.03885.x )","DOI":"10.1111\/j.1749-6632.2009.03885.x"},{"key":"9087_CR57","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1046\/j.1471-4159.2001.00183.x","volume":"76","author":"S Przedborski","year":"2001","unstructured":"Przedborski S, Jackson-Lewis V, Naini AB, Jakowec M, Petzinger G, Miller R, Akran M (2001) The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a technical review of its utility and safety. J Neurochem 76:1265\u20131274","journal-title":"J Neurochem"},{"key":"9087_CR58","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/BF01249445","volume":"38","author":"P Riederer","year":"1976","unstructured":"Riederer P, Wuketich S (1976) Time course of nigrostriatal degeneration in parkinson\u2019s disease. A detailed study of influential factors in human brain amine analysis. J Neural Transm 38:277\u2013301","journal-title":"J Neural Transm"},{"key":"9087_CR59","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1111\/j.1460-9568.2006.05060.x","volume":"24","author":"AI Rojo","year":"2006","unstructured":"Rojo AI, Montero C, Salazar M, Close RM, Fernandez-Ruiz J, Sanchez-Gonzalez MA, de Sagarra MR, Jackson-Lewis V, Cavada C, Cuadrado A (2006) Persistent penetration of MPTP through the nasal route induces Parkinson\u2019s disease in mice. Eur J Neurosci 24:1874\u20131884","journal-title":"Eur J Neurosci"},{"key":"9087_CR60","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1097\/00001756-199210000-00003","volume":"3","author":"M Sallaz","year":"1992","unstructured":"Sallaz M, Jourdan F (1992) Apomorphine disrupts odour-induced patterns of glomerular activation in the olfactory bulb. Neuroreport 3:833\u2013836","journal-title":"Neuroreport"},{"key":"9087_CR61","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0022-3565(24)37972-8","volume":"288","author":"MS Saporito","year":"1999","unstructured":"Saporito MS, Brown EM, Miller MS, Carswell S (1999) CEP-1347\/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons in vivo. J Pharmacol Exp Ther 288:421\u2013427","journal-title":"J Pharmacol Exp Ther"},{"key":"9087_CR62","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s12640-009-9061-x","volume":"16","author":"N Schintu","year":"2009","unstructured":"Schintu N, Frau L, Ibba M, Garau A, Carboni E, Carta AR (2009) Progressive dopaminergic degeneration in the chronic MPTPp mouse model of Parkinson\u2019s disease. Neurotox Res 16:127\u2013139","journal-title":"Neurotox Res"},{"key":"9087_CR63","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1007\/s007020100004","volume":"108","author":"N Schmidt","year":"2001","unstructured":"Schmidt N, Ferger B (2001) Neurochemical findings in the MPTP model of Parkinson\u2019s disease. J Neural Transm 108:1263\u20131282","journal-title":"J Neural Transm"},{"key":"9087_CR64","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1007\/s00415-004-0483-3","volume":"251","author":"A Schrag","year":"2004","unstructured":"Schrag A (2004) Psychiatric aspects of Parkinson\u2019s disease: an update. J Neurol 251:795\u2013804","journal-title":"J Neurol"},{"key":"9087_CR65","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1023\/A:1001958023096","volume":"30","author":"M Sedelis","year":"2000","unstructured":"Sedelis M, Hofele K, Auburger GW, Morgan S, Huston JP, Schwarting RK (2000) MPTP susceptibility in the mouse: behavioral, nurochemical, and histological analysis of gender and strain differences. Behav Genet 30:171\u2013182","journal-title":"Behav Genet"},{"key":"9087_CR66","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/0006-8993(85)90537-2","volume":"329","author":"MT Shipley","year":"1985","unstructured":"Shipley MT, Halloran FJ, de la Torre J (1985) Surprisingly rich projection from locus coeruleus to the olfactory bulb in the rat. Brain Res 329:294\u2013299","journal-title":"Brain Res"},{"key":"9087_CR67","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/S0028-3932(98)00068-2","volume":"37","author":"GT Stebbins","year":"1999","unstructured":"Stebbins GT, Gabrieli JD, Masciari F, Monti L, Goetz CG (1999) Delayed recognition memory in Parkinson\u2019s disease: a role for working memory? Neuropsychologia 37:503\u2013510","journal-title":"Neuropsychologia"},{"key":"9087_CR68","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.neuroscience.2008.08.035","volume":"156","author":"MT Tadaiesky","year":"2008","unstructured":"Tadaiesky MT, Dombrowski PA, Figueiredo CP, Cargnin-Ferreira E, Da Cunha C, Takahashi RN (2008) Emotional, cognitive and neurochemical alterations in a premotor stage model of Parkinson\u2019s disease. Neuroscience 156:830\u2013840","journal-title":"Neuroscience"},{"key":"9087_CR69","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1037\/0735-7044.105.3.450","volume":"105","author":"DA Weldon","year":"1991","unstructured":"Weldon DA, Travis ML, Kennedy DA (1991) Posttraining D1 receptor blockade impairs odor conditioning in neonatal rats. Behav Neurosci 105:450\u2013458","journal-title":"Behav Neurosci"},{"key":"9087_CR70","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.brainres.2008.08.097","volume":"1241","author":"JC Xikota","year":"2008","unstructured":"Xikota JC, Rial D, Ruthes D, Pereira R, Figueiredo CP, Prediger RD, Walz R (2008) Mild cognitive deficits associated to neocortical microgyria in mice with genetic deletion of cellular prion protein. Brain Res 1241:148\u2013156","journal-title":"Brain Res"},{"key":"9087_CR71","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/00146965-200312000-00001","volume":"16","author":"DJ Zgaljardic","year":"2003","unstructured":"Zgaljardic DJ, Borod JC, Foldi NS, Mattis P (2003) A review of the cognitive and behavioral sequelae of Parkinson\u2019s disease: relationship to frontostriatal circuitry. Cogn Behav Neurol 16:193\u2013210","journal-title":"Cogn Behav Neurol"}],"container-title":["Neurotoxicity Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-009-9087-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12640-009-9087-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-009-9087-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-009-9087-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:26:22Z","timestamp":1739233582000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12640-009-9087-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,21]]},"references-count":71,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["9087"],"URL":"https:\/\/doi.org\/10.1007\/s12640-009-9087-0","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.2818959.2484057","asserted-by":"object"}]},"ISSN":["1029-8428","1476-3524"],"issn-type":[{"value":"1029-8428","type":"print"},{"value":"1476-3524","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,21]]}}}